Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Philipp Kasper, Münevver Demir, Hans-Michael Steffen

Clin Mol Hepatol. 2023;29(2):390-393. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0059

View: 630 Download: 19

Qian Jin, Rui-Xu Yang, Jian-Gao Fan

Clin Mol Hepatol. 2022;28(3):473-477. Published online June 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0155

View: 2025 Download: 70 Citations: 2

Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim

Clin Mol Hepatol. 2021;27(2):221-235. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0239

View: 5602 Download: 326 Citations: 22

Moon Young Kim , Soon Koo Baik

Clin Mol Hepatol. 2008;14(1):1-3. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.1

View: 4262 Download: 59 Citations: 2

1 |

Viewed By 4171	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 3577	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 2850	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2797	Recent updates on the management of autoimmune hepatitis
Viewed By 2719	Identification of high-risk subjects in nonalcoholic fatty liver disease

Cited By 99	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 42	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 42	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 40	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 38	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search